Brendan Bulik-Sullivan

Brendan Bulik-Sullivan is a highly experienced professional in the life sciences sector, currently serving as a General Partner at GV since 2019. Brendan holds directorial positions at multiple companies, including Santa Ana Bio, AreteiaTx, Comanche Biopharma, Ventus Therapeutics, and Maze Therapeutics. Prior experience includes a role in machine learning at Gritstone Oncology and work in statistical genetics at the Broad Institute. Brendan Bulik-Sullivan earned a Bachelor of Arts in Mathematics from the University of California, Berkeley, and a Doctor of Philosophy in Statistical Genetics from Vrije Universiteit Amsterdam.